VIR : hold on and be patient

Vir Biotechnology, Inc.NASDAQ

Description

⋅ May 10, 2022 7:32 PM

After the very good results of the first quarter,the stock reacted well. The hepatitis cases remain under control. The company's balance sheet is clean and this gives hope for the future...

Beyond Technical Analysis VIR